<DOC>
	<DOCNO>NCT02014805</DOCNO>
	<brief_summary>The purpose study determine whether postoperative conformal radiotherapy effective treatment Masaoka stage II-III B type thymoma .</brief_summary>
	<brief_title>Postoperative Conformal Radiotherapy Stage II-III B Type Thymoma</brief_title>
	<detailed_description>The role postoperative radiotherapy thymoma controversial . Some retrospective study radiotherapy , others . However , inherent bias exist trial . Resection , Masaoka stage pathology widely accept prognostic factor thymoma . Furthermore , frequency local failure radical resection still high Masaoka stage II-III B type thymoma . With conformal technique appear , conformal radiotherapy escalate dose without increase risk normal tissue toxicity .</detailed_description>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<criteria>Age 1875 , ZubrodECOGWHO 02 , interval surgery radiotherapy &lt; 2months , Masaoka stage IIIII WHO B type thymoma No second primary tumor , serious comorbidity , neoadjuvant anticancer treatment , adjuvant chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>postoperative</keyword>
	<keyword>conformal</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>thymoma</keyword>
</DOC>